Table: Stemcell Institute -Q1 group results
Aug 6 (Reuters)-
Stemcell Institute
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2026 Jun 30, 2025 Mar 31, 2027
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 722 mln 3.10
(+10.3 pct)
Operating 40 mln 100 mln
(-50.7 pct)
Recurring 43 mln 100 mln
(-54.0 pct)
Net 35 mln 105 mln
(-32.7 pct)
EPS 3.57 yen 10.32 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Stemcell Institute.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7096.T